BRCA2 and ovarian carcinoma: The lifetime ovarian cancer risk for a woman with BRCA1 mutation is estimated to be 35% to 70%, the ovarian cancer risk lifetime for women with BRCA2 mutation is between 10 and 30%; the ovarian cancer lifetime risk for the women in the general population is less than 2%.